EPZM Annual EBITDA
-$221.69 M
-$161.00 K-0.07%
31 December 2021
Summary:
As of February 5, 2025, EPZM annual earnings before interest, taxes, depreciation & amortization is -$221.69 million, with the most recent change of -$161.00 thousand (-0.07%) on December 31, 2021. During the last 3 years, it has fallen by -$99.17 million (-80.94%).EPZM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM Quarterly EBITDA
-$28.48 M
+$19.72 M+40.92%
30 June 2022
Summary:
As of February 5, 2025, EPZM quarterly earnings before interest, taxes, depreciation & amortization is -$28.48 million, with the most recent change of +$19.72 million (+40.92%) on June 30, 2022. Over the past year, it has increased by +$28.47 million (+49.99%).EPZM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM TTM EBITDA
-$178.36 M
+$28.47 M+13.77%
30 June 2022
Summary:
As of February 5, 2025, EPZM TTM earnings before interest, taxes, depreciation & amortization is -$178.36 million, with the most recent change of +$28.47 million (+13.77%) on June 30, 2022. Over the past year, it has increased by +$55.53 million (+23.74%).EPZM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPZM EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.1% | +50.0% | +23.7% |
| 3 y3 years | -80.9% | +41.0% | -5.4% |
| 5 y5 years | -66.7% | -1.5% | -5.4% |
EPZM EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | <-9999.0% | -273.4% | -4339.7% |
Epizyme EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$28.48 M(-40.9%) | -$178.36 M(-13.8%) |
| Mar 2022 | - | -$48.21 M(+11.5%) | -$206.83 M(-6.7%) |
| Dec 2021 | -$221.69 M(+0.1%) | -$43.25 M(-26.0%) | -$221.65 M(-7.3%) |
| Sept 2021 | - | -$58.42 M(+2.6%) | -$239.23 M(+2.3%) |
| June 2021 | - | -$56.95 M(-9.6%) | -$233.89 M(+0.1%) |
| Mar 2021 | - | -$63.02 M(+3.6%) | -$233.67 M(+5.8%) |
| Dec 2020 | -$221.53 M(+30.9%) | -$60.83 M(+14.6%) | -$220.78 M(+2.3%) |
| Sept 2020 | - | -$53.09 M(-6.4%) | -$215.88 M(+8.7%) |
| June 2020 | - | -$56.73 M(+13.2%) | -$198.68 M(+4.5%) |
| Mar 2020 | - | -$50.13 M(-10.4%) | -$190.20 M(+12.4%) |
| Dec 2019 | -$169.21 M(+38.1%) | -$55.94 M(+55.9%) | -$169.20 M(+27.4%) |
| Sept 2019 | - | -$35.88 M(-25.6%) | -$132.79 M(-1.8%) |
| June 2019 | - | -$48.26 M(+65.6%) | -$135.25 M(+15.6%) |
| Mar 2019 | - | -$29.13 M(+49.2%) | -$117.03 M(-4.5%) |
| Dec 2018 | -$122.52 M(-7.9%) | -$19.53 M(-49.1%) | -$122.52 M(-11.1%) |
| Sept 2018 | - | -$38.33 M(+27.6%) | -$137.75 M(+0.5%) |
| June 2018 | - | -$30.04 M(-13.2%) | -$137.06 M(+1.5%) |
| Mar 2018 | - | -$34.62 M(-0.4%) | -$135.07 M(+1.6%) |
| Dec 2017 | -$133.01 M | -$34.76 M(-7.7%) | -$133.01 M(-0.2%) |
| Sept 2017 | - | -$37.65 M(+34.2%) | -$133.33 M(+11.0%) |
| June 2017 | - | -$28.05 M(-13.8%) | -$120.11 M(+0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$32.55 M(-7.2%) | -$120.06 M(+8.9%) |
| Dec 2016 | -$110.24 M(-15.9%) | -$35.09 M(+43.6%) | -$110.24 M(+13.6%) |
| Sept 2016 | - | -$24.43 M(-12.8%) | -$97.07 M(+1.8%) |
| June 2016 | - | -$28.00 M(+23.2%) | -$95.34 M(+2.8%) |
| Mar 2016 | - | -$22.73 M(+3.7%) | -$92.74 M(-29.3%) |
| Dec 2015 | -$131.13 M(+141.5%) | -$21.92 M(-3.4%) | -$131.13 M(+5.7%) |
| Sept 2015 | - | -$22.70 M(-10.6%) | -$124.11 M(+2.6%) |
| June 2015 | - | -$25.39 M(-58.5%) | -$120.96 M(+11.3%) |
| Mar 2015 | - | -$61.12 M(+310.3%) | -$108.68 M(+100.1%) |
| Dec 2014 | -$54.31 M(+2140.4%) | -$14.90 M(-23.8%) | -$54.31 M(+136.2%) |
| Sept 2014 | - | -$19.55 M(+49.0%) | -$22.99 M(+76.9%) |
| June 2014 | - | -$13.12 M(+94.5%) | -$12.99 M(+595.2%) |
| Mar 2014 | - | -$6.74 M(-141.1%) | -$1.87 M(-22.9%) |
| Dec 2013 | -$2.42 M(-3168.4%) | $16.42 M(-271.9%) | -$2.42 M(-89.4%) |
| Sept 2013 | - | -$9.56 M(+379.5%) | -$22.98 M(+160.3%) |
| June 2013 | - | -$1.99 M(-72.7%) | -$8.83 M(+369.1%) |
| Mar 2013 | - | -$7.30 M(+76.8%) | -$1.88 M(-2482.3%) |
| Dec 2012 | $79.00 K(-100.4%) | -$4.13 M(-189.9%) | $79.00 K(-98.1%) |
| Sept 2012 | - | $4.59 M(-7.3%) | $4.21 M(-1195.6%) |
| June 2012 | - | $4.95 M(-192.8%) | -$384.00 K(-92.8%) |
| Mar 2012 | - | -$5.34 M | -$5.34 M |
| Dec 2011 | -$20.49 M | - | - |
FAQ
- What is Epizyme annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Epizyme?
- What is Epizyme annual EBITDA year-on-year change?
- What is Epizyme quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Epizyme?
- What is Epizyme quarterly EBITDA year-on-year change?
- What is Epizyme TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Epizyme?
- What is Epizyme TTM EBITDA year-on-year change?
What is Epizyme annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of EPZM is -$221.69 M
What is the all time high annual EBITDA for Epizyme?
Epizyme all-time high annual earnings before interest, taxes, depreciation & amortization is $79.00 K
What is Epizyme annual EBITDA year-on-year change?
Over the past year, EPZM annual earnings before interest, taxes, depreciation & amortization has changed by -$161.00 K (-0.07%)
What is Epizyme quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of EPZM is -$28.48 M
What is the all time high quarterly EBITDA for Epizyme?
Epizyme all-time high quarterly earnings before interest, taxes, depreciation & amortization is $16.42 M
What is Epizyme quarterly EBITDA year-on-year change?
Over the past year, EPZM quarterly earnings before interest, taxes, depreciation & amortization has changed by +$28.47 M (+49.99%)
What is Epizyme TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of EPZM is -$178.36 M
What is the all time high TTM EBITDA for Epizyme?
Epizyme all-time high TTM earnings before interest, taxes, depreciation & amortization is $4.21 M
What is Epizyme TTM EBITDA year-on-year change?
Over the past year, EPZM TTM earnings before interest, taxes, depreciation & amortization has changed by +$55.53 M (+23.74%)